轻中度COVID-19后持续心肺症状患者的心脏MRI表现
前瞻性研究纳入41例轻中度COVID-19后持续心肺症状(慢性COVID-19综合征)患者和42例健康对照,行心脏MRI评估心肌损伤和炎症。结果显示两组T1、T2弛豫时间及T2信号强度比无显著差异,无患者符合2018 Lake Louise心肌炎诊断标准,提示这些患者无活动性心肌损伤或炎症证据。
要点
- 轻中度COVID-19后持续症状患者心脏MRI未见活动性心肌损伤或炎症征象。
- T1、T2弛豫时间及T2信号强度比与健康对照无显著差异。
- 仅7%患者出现非缺血性LGE,未达心肌炎诊断标准。
关键影像表现/征象
- 可见心肌水肿在两组中均不存在。
诊断标准与关键数值
- 无患者符合2018 Lake Louise心肌炎诊断标准。
临床应用与阅片要点
- 对轻中度COVID-19后持续心肺症状患者,心脏MRI不应常规提示活动性心肌炎。
- 非缺血性LGE可见于少数患者,但需结合临床,不单独诊断心肌炎。
局限性
- 样本量较小(41例患者和42例对照)。
- 单中心前瞻性研究。
- 未报告细胞外容积和T2信号强度比的具体统计值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background Myocardial injury and inflammation at cardiac MRI in patients with COVID-19 have been described in recent publications. Concurrently, a chronic COVID-19 syndrome (CCS) after SARS-CoV-2 infection has been observed and manifests with symptoms such as fatigue and exertional dyspnea. Purpose To explore the relationship between CCS and myocardial injury and inflammation as an underlying cause of the persistent complaints in previously healthy individuals. Materials and Methods In this prospective study from January 2021 to April 2021, study participants without known cardiac or pulmonary diseases prior to SARS-CoV-2 infection who had persistent CCS symptoms such as fatigue or exertional dyspnea after convalescence and healthy control participants underwent cardiac MRI. The cardiac MRI protocol included evaluating the T1 and T2 relaxation times, extracellular volume, T2 signal intensity ratio, and late gadolinium enhancement (LGE). Student t tests, Mann-Whitney U tests, and χ2 tests were used for statistical analysis. Results Forty-one participants with CCS (mean age, 39 years ± 13 [standard deviation]; 18 men) and 42 control participants (mean age, 39 years ± 16; 26 men) were evaluated. The median time between the initial incidence of mild to moderate COVID-19 not requiring hospitalization and undergoing cardiac MRI was 103 days (interquartile range, 88-158 days). Troponin T levels were normal. Parameters indicating myocardial inflammation and edema were comparable between participants with CCS and control participants (T1 relaxation times: 978 msec ± 23 vs 971 msec ± 25 [P = .17]; T2 relaxation times: 53 msec ± 2 vs 52 msec ± 2 [P = .47]; T2 signal intensity ratios: 1.6 ± 0.2 vs 1.6 ± 0.3 [P = .10]). Visible myocardial edema was present in none of the participants. Three of 41 (7%) participants with CCS demonstrated nonischemic LGE, whereas no participants in the control group demonstrated nonischemic LGE (0 of 42 [0%]; P = .07). None of the participants fulfilled the 2018 Lake Louise criteria for the diagnosis of myocarditis. Conclusion Individuals with chronic COVID-19 syndrome who did not undergo hospitalization for COVID-19 did not demonstrate signs of active myocardial injury or inflammation at cardiac MRI. © RSNA, 2021 Online supplemental material is available for this article. See also the editorial by Lima and Bluemke in this issue.
引用
- Kravchenko D, Isaak A, Zimmer S, et al. Cardiac MRI in Patients with Prolonged Cardiorespiratory Symptoms after Mild to Moderate COVID-19. Radiology. 2021. PMID: 34374593. doi:10.1148/radiol.2021211162
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。